Utama › Kanser Paru-paru › North Dakota › Bismarck
Kajian klinikal Kanser Paru-paru di Bismarck, ND
9 kajian untuk Kanser Paru-paru sedang mencari peserta di lokasi dalam dan sekitar Bismarck (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial
Mengambil pesertaFasa 3
- Sanford Bismarck Medical Center, Bismarck
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Mengambil pesertaFasa 3
- Sanford Bismarck Medical Center, Bismarck
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
- Sanford Bismarck Medical Center, Bismarck
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
Mengambil pesertaFasa 3
- Sanford Bismarck Medical Center, Bismarck
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
Mengambil pesertaFasa 3
- Sanford Bismarck Medical Center, Bismarck
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
Mengambil pesertaFasa 2
- Sanford Bismarck Medical Center, Bismarck
Promoting Radon Testing Among Mothers of Young Children
Mengambil pesertaSukarelawan sihat dialu-alukan
- University of North Dakota Center for Family Medicine, Bismarck Clinic, Bismarck
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
Mengambil pesertaFasa 2/3
- Sanford Bismarck Medical Center, Bismarck
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
Mengambil pesertaFasa 2
- Sanford Bismarck Medical Center, Bismarck
Kajian Kanser Paru-paru di bandar lain
- Houston, TX78 kajian
- Boston, MA62 kajian
- New York City, NY60 kajian
- Los Angeles, CA45 kajian
- Arlington, VA41 kajian
- Washington, DC41 kajian
- Chicago, IL41 kajian
- Baltimore, MD40 kajian
- Nashville, TN40 kajian
- St. Louis, MO39 kajian
- Columbus, OH37 kajian
- Philadelphia, PA36 kajian
Kajian lain di Bismarck
- Kanser Paru-paru Bukan Sel Kecil6 kajian
- Karsinoma Sel Skuamosa Kepala dan Leher5 kajian
- Kanser Payudara3 kajian
- Kanser Pankreas3 kajian
- Kanser Rektum3 kajian
- Kanser Kolon3 kajian
- Kanser Prostat3 kajian
- Kanser Hipofaring3 kajian
- Kanser Laring3 kajian
- Kanser Oral3 kajian
- Kanser Kolorektal3 kajian
- Melanoma3 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 6 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.